Skip to main content
Top

16-06-2015 | Systemic lupus erythematosus | Review | Article

Epigenetic Aspects of Systemic Lupus Erythematosus

Journal: Rheumatology and Therapy

Authors: Manfred Relle, Bernd Foehr, Andreas Schwarting

Publisher: Springer Healthcare

Abstract

Autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, autoimmune hepatitis, and inflammatory bowel disease have complex pathogeneses and the courses of events leading to these diseases are not well understood. The immune surveillance is a delicate balance between self and foreign as well as between tolerance and immune response. Exposure to certain environmental factors may impair this equilibrium, leading to autoimmune diseases, cancer, and the so-called “lifestyle diseases” such as atherosclerosis, heart attack, stroke, and obesity, among others. These external stimuli may also alter the epigenetic status quo and may trigger autoimmune diseases such as SLE in genetically susceptible individuals. This review aims to highlight the role of epigenetic (dys-)regulation in the pathogenesis of SLE.
Literature
1.
Block SR, et al. Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am J Med. 1975;59(4):533–52.PubMed
2.
Block SR, et al. Proceedings: twin studies in systemic lupus erythematosus (SLE). Arthritis Rheum. 1975;18(3):285.PubMed
3.
Gregersen PK. Discordance for autoimmunity in monozygotic twins. Are “identical” twins really identical? Arthritis Rheum. 1993;36(9):1185–92.PubMed
4.
Kaplan D. The onset of disease in twins and siblings with systemic lupus erythematosus. J Rheumatol. 1984;11(5):648–52.PubMed
5.
Waddington CH. The epigenotype. Endeavour. 1942;1:18–20.
6.
Valley CM, Willard HF. Genomic and epigenomic approaches to the study of X chromosome inactivation. Curr Opin Genet Dev. 2006;16(3):240–5.PubMed
7.
Riggs AD. X inactivation, differentiation, and DNA methylation. Cytogenet Cell Genet. 1975;14(1):9–25.PubMed
8.
Buiting K. Prader-Willi syndrome and Angelman syndrome. Am J Med Genet C Semin Med Genet. 2010;154C(3):365–76.PubMed
9.
Henry I, et al. Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature. 1991;351(6328):665–7.PubMed
10.
Viljoen D, Ramesar R. Evidence for paternal imprinting in familial Beckwith-Wiedemann syndrome. J Med Genet. 1992;29(4):221–5.PubMedCentralPubMed
11.
Watson JD, Crick FH. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature. 1953;171(4356):737–8.PubMed
12.
Cavalli G. Chromatin and epigenetics in development: blending cellular memory with cell fate plasticity. Development. 2006;133(11):2089–94.PubMed
13.
Kornberg RD. Chromatin structure: a repeating unit of histones and DNA. Science. 1974;184(139):868–71.PubMed
14.
Brownell JE, et al. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell. 1996;84(6):843–51.PubMed
15.
Taunton J, Hassig CA, Schreiber SL. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science. 1996;272(5260):408–11.PubMed
16.
Rea S, et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature. 2000;406(6796):593–9.PubMed
17.
Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell. 2007;128(4):707–19.PubMed
18.
Groth A, et al. Chromatin challenges during DNA replication and repair. Cell. 2007;128(4):721–33.PubMed
19.
Kohn KW, et al. Chromatin challenges during DNA replication: a systems representation. Mol Biol Cell. 2008;19(1):1–7.PubMedCentralPubMed
20.
Cosgrove MS, Boeke JD, Wolberger C. Regulated nucleosome mobility and the histone code. Nat Struct Mol Biol. 2004;11(11):1037–43.PubMed
21.
Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403(6765):41–5.PubMed
22.
Church DM, et al. Lineage-specific biology revealed by a finished genome assembly of the mouse. PLoS Biol. 2009;7(5):e1000112.PubMedCentralPubMed
23.
Lander ES, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409(6822):860–921.PubMed
24.
Waterston RH, et al. Initial sequencing and comparative analysis of the mouse genome. Nature. 2002;420(6915):520–62.PubMed
25.
Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling. Trends Mol Med. 2007;13(9):373–80.PubMedCentralPubMed
26.
Turner BM. Histone acetylation and an epigenetic code. BioEssays. 2000;22(9):836–45.PubMed
27.
Gregoretti IV, Lee YM, Goodson HV. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol. 2004;338(1):17–31.PubMed
28.
Gray SG, Ekstrom TJ. The human histone deacetylase family. Exp Cell Res. 2001;262(2):75–83.PubMed
29.
Leipe DD, Landsman D. Histone deacetylases, acetoin utilization proteins and acetylpolyamine amidohydrolases are members of an ancient protein superfamily. Nucleic Acids Res. 1997;25(18):3693–7.PubMedCentralPubMed
30.
Shakespear MR, et al. Histone deacetylases as regulators of inflammation and immunity. Trends Immunol. 2011;32(7):335–43.PubMed
31.
Wallrath LL. Unfolding the mysteries of heterochromatin. Curr Opin Genet Dev. 1998;8(2):147–53.PubMed
32.
Kwon SH, Workman JL. The heterochromatin protein 1 (HP1) family: put away a bias toward HP1. Mol Cells. 2008;26(3):217–27.PubMed
33.
Lomberk G, et al. Evidence for the existence of an HP1-mediated subcode within the histone code. Nat Cell Biol. 2006;8(4):407–15.PubMed
34.
Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet. 2000;9(16):2395–402.PubMed
35.
Okano M, et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99(3):247–57.PubMed
36.
Lei H, et al. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development. 1996;122(10):3195–205.PubMed
37.
Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 1992;69(6):915–26.PubMed
38.
Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci. 2006;31(2):89–97.PubMed
39.
Kouzarides T. Chromatin modifications and their function. Cell. 2007;128(4):693–705.PubMed
40.
Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293(5532):1074–80.PubMed
41.
Ballestar E, Esteller M, Richardson BC. The epigenetic face of systemic lupus erythematosus. J Immunol. 2006;176(12):7143–7.PubMed
42.
Wakeland EK, et al. Genetic dissection of systemic lupus erythematosus. Curr Opin Immunol. 1999;11(6):701–7.PubMed
43.
Shapira Y, Agmon-Levin N, Shoenfeld Y. Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol. 2010;6(8):468–76.PubMed
44.
Holliday R, Pugh JE. DNA modification mechanisms and gene activity during development. Science. 1975;187(4173):226–32.PubMed
45.
Wolffe AP, Matzke MA. Epigenetics: regulation through repression. Science. 1999;286(5439):481–6.PubMed
46.
Richardson B, Yung R. Role of DNA methylation in the regulation of cell function. J Lab Clin Med. 1999;134(4):333–40.PubMed
47.
Nakao M. Epigenetics: interaction of DNA methylation and chromatin. Gene. 2001;278(1–2):25–31.PubMed
48.
Cooper DN, Krawczak M. Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes. Hum Genet. 1989;83(2):181–8.PubMed
49.
Fatemi M, et al. Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level. Nucleic Acids Res. 2005;33(20):e176.PubMedCentralPubMed
50.
Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16(1):6–21.PubMed
51.
Lu Q, et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum. 2002;46(5):1282–91.PubMed
52.
Richardson B, Ray D, Yung R. Murine models of lupus induced by hypomethylated T cells. Methods Mol Med. 2004;102:285–94.PubMedCentralPubMed
53.
Cornacchia E, et al. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol. 1988;140(7):2197–200.PubMed
54.
Scheinbart LS, et al. Procainamide inhibits DNA methyltransferase in a human T cell line. J Rheumatol. 1991;18(4):530–4.PubMed
55.
Richardson B. Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells. Hum Immunol. 1986;17(4):456–70.PubMed
56.
Sawalha AH, Jeffries M. Defective DNA methylation and CD70 overexpression in CD4+ T cells in MRL/lpr lupus-prone mice. Eur J Immunol. 2007;37(5):1407–13.PubMed
57.
Caricchio R, McPhie L, Cohen PL. Ultraviolet B radiation-induced cell death: critical role of ultraviolet dose in inflammation and lupus autoantigen redistribution. J Immunol. 2003;171(11):5778–86.PubMed
58.
Sanders CJ, et al. Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br J Dermatol. 2003;149(1):131–7.PubMed
59.
Zhu XH, et al. Effects of ultraviolet B exposure on DNA methylation in patients with systemic lupus erythematosus. Exp Ther Med. 2013;5(4):1219–25.PubMedCentralPubMed
60.
Richardson B, et al. Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity. Arthritis Rheum. 1994;37(9):1363–72.PubMed
61.
Yung R, et al. Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice. J Clin Invest. 1996;97(12):2866–71.PubMedCentralPubMed
62.
Luo Y, Zhao M, Lu Q. Demethylation of promoter regulatory elements contributes to CD70 overexpression in CD4+ T cells from patients with subacute cutaneous lupus erythematosus. Clin Exp Dermatol. 2010;35(4):425–30.PubMed
63.
Balada E, et al. Associations between the expression of epigenetically regulated genes and the expression of DNMTs and MBDs in systemic lupus erythematosus. Plos One. 2012;7(9):e45356.
64.
Kobata T, et al. CD27-CD70 interactions regulate B-cell activation by T cells. Proc Natl Acad Sci. 1995;92(24):11249–53.PubMedCentralPubMed
65.
Lu Q, Wu A, Richardson BC. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J Immunol. 2005;174(10):6212–9.PubMed
66.
Zhao M, et al. Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. J Autoimmun. 2010;35(1):58–69.PubMed
67.
Rupasree Y, et al. Epigenetic modulation of RFC1, MHC2TA and HLA-DR in systemic lupus erythematosus: association with serological markers and six functional polymorphisms of one-carbon metabolic pathway. Gene. 2014;536(1):45–52.PubMed
68.
Javierre BM, Richardson B. A new epigenetic challenge: systemic lupus erythematosus. Adv Exp Med Biol. 2011;711:117–36.PubMed
69.
Coit P, et al. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients. J Autoimmun. 2013;43:78–84.PubMedCentralPubMed
70.
Absher DM, et al. Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. Plos Genet. 2013;9(8):e1003678.
71.
Coit P, et al. Epigenome profiling reveals significant DNA demethylation of interferon signature genes in lupus neutrophils. J Autoimmun. 2015;58:59–66.PubMed
72.
Sawalha AH, et al. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun. 2008;9(4):368–78.PubMedCentralPubMed
73.
Gorelik G, Richardson B. Key role of ERK pathway signaling in lupus. Autoimmunity. 2010;43(1):17–22.PubMedCentralPubMed
74.
Strickland FM, et al. Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus. J Autoimmun. 2011;38(2–3):J135–43.
75.
Gorelik GJ, Yarlagadda S, Richardson BC. Protein kinase C delta oxidation contributes to ERK inactivation in lupus T cells. Arthritis Rheum. 2012;64(9):2964–74.PubMedCentralPubMed
76.
Zhou Y, et al. T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clin Immunol. 2009;132(3):362–70.PubMedCentralPubMed
77.
Mi XB, Zeng FQ. Hypomethylation of interleukin-4 and -6 promoters in T cells from systemic lupus erythematosus patients. Acta Pharmacol Sin. 2008;29(1):105–12.PubMed
78.
Richardson B. DNA methylation and autoimmune disease. Clin Immunol. 2003;109(1):72–9.PubMed
79.
Garaud S, et al. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J Immunol. 2009;182(9):5623–32.PubMed
80.
Zhao M, et al. Hypomethylation of IL10 and IL13 promoters in CD4+ T cells of patients with systemic lupus erythematosus. J Biomed Biotechnol. 2010;2010:931018.PubMedCentralPubMed
81.
Lin SY, et al. A whole genome methylation analysis of systemic lupus erythematosus: hypomethylation of the IL10 and IL1R2 promoters is associated with disease activity. Genes Immun. 2012;13(3):214–20.PubMed
82.
Kaplan MJ, et al. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J Immunol. 2004;172(6):3652–61.PubMed
83.
Luo Y, et al. DNA demethylation of the perforin promoter in CD4(+) T cells from patients with subacute cutaneous lupus erythematosus. J Dermatol Sci. 2009;56(1):33–6.PubMed
84.
Hedrich CM, et al. cAMP response element modulator alpha controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus. Proc Natl Acad Sci. 2012;109(41):16606–11.PubMedCentralPubMed
85.
Hedrich CM, et al. cAMP responsive element modulator (CREM) alpha mediates chromatin remodeling of CD8 during the generation of CD3(+)CD4(−)CD8(−) T Cells. J Biol Chem. 2014;289(4):2361–70.PubMedCentralPubMed
86.
Zhang Q, et al. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus. J Autoimmun. 2011;37(3):180–9.PubMed
87.
Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet. 2009;10(5):295–304.PubMed
88.
Bird AP, Wolffe AP. Methylation-induced repression–belts, braces, and chromatin. Cell. 1999;99(5):451–4.PubMed
89.
Issa JP, et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 1994;7(4):536–40.PubMed
90.
Hu N, et al. Abnormal histone modification patterns in lupus CD4+ T cells. J Rheumatol. 2008;35(5):804–10.PubMed
91.
Zhou Y, et al. Histone modifications and methyl-CpG-binding domain protein levels at the TNFSF7 (CD70) promoter in SLE CD4+ T cells. Lupus. 2011;20(13):1365–71.PubMed
92.
Kuo MH, Allis CD. Roles of histone acetyltransferases and deacetylases in gene regulation. BioEssays. 1998;20(8):615–26.PubMed
93.
Peserico A, Simone C. Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J Biomed Biotechnol. 2011;2011:371832.PubMedCentralPubMed
94.
Long H, et al. Abnormal expression pattern of histone demethylases in CD4(+) T cells of MRL/lpr lupus-like mice. Lupus. 2009;18(14):1327–8.PubMed
95.
Regna NL, et al. Class I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo. Clin Immunol. 2014;151(1):29–42.PubMedCentralPubMed
96.
Zhao M, et al. RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1. Arthritis Res Ther. 2011;12(6):R227.
97.
Sui W, et al. Genome-wide analysis of 5-hmC in the peripheral blood of systemic lupus erythematosus patients using an hMeDIP-chip. Int J Mol Med. 2015;35(5):1467–79.PubMed
98.
Wyatt GR, Cohen SS. A new pyrimidine base from bacteriophage nucleic acids. Nature. 1952;170(4338):1072–3.PubMed
99.
Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in purkinje neurons and the brain. Science. 2009;324(5929):929–30.PubMedCentralPubMed
100.
Tahiliani M, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324(5929):930–5.PubMedCentralPubMed
101.
Guo JU, et al. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell. 2011;145(3):423–34.PubMedCentralPubMed
102.
Bachman M, et al. 5-Hydroxymethylcytosine is a predominantly stable DNA modification. Nat Chem. 2014;6(12):1049–55.PubMedCentralPubMed
103.
Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–54.PubMed
104.
Elbashir SM, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411(6836):494–8.PubMed
105.
Lee R, Feinbaum R, Ambros V. A short history of a short RNA. Cell. 2004;116(2 Suppl):S89–92 (1 p following S96).
106.
Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 2001;15(2):188–200.PubMedCentralPubMed
107.
Lagos-Quintana M, et al. Identification of novel genes coding for small expressed RNAs. Science. 2001;294(5543):853–8.PubMed
108.
Lau NC, et al. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science. 2001;294(5543):858–62.PubMed
109.
Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350–5.PubMed
110.
Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–33.PubMedCentralPubMed
111.
Stagakis E, et al. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis. 2011;70(8):1496–506.PubMed
112.
Garzon R, et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood. 2009;113(25):6411–8.PubMedCentralPubMed
113.
Fabbri M, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci. 2007;104(40):15805–10.PubMedCentralPubMed
114.
Tang Y, et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009;60(4):1065–75.PubMed
115.
Te JL, et al. Identification of unique microRNA signature associated with lupus nephritis. PLoS One. 2010;5(5):e10344.PubMedCentralPubMed
116.
Dai Y, et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus. 2007;16(12):939–46.PubMed
117.
Pan W, et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol. 2010;184(12):6773–81.PubMed
118.
Zhao S, et al. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum. 2011;63(5):1376–86.
119.
Liang Y, et al. DNA methylation status of miR-126 and its host gene EGFL7 in CD4+ T cells from patients with systemic lupus erythematosus. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013;38(8):793–7.PubMed
120.
Lu MM, et al. Increased serum RANTES in patients with systemic lupus erythematosus. Rheumatol Int. 2012;32(5):1231–3.PubMed
121.
Zhao X, et al. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum. 2010;62(11):3425–35.PubMed
122.
Nojima J, et al. Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients. Biochem Biophys Res Commun. 2008;365(1):195–200.PubMed
123.
Teruel R, et al. Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome. J Thromb Haemost. 2011;9(10):1985–92.PubMed
124.
Deng Y, et al. MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus. Plos Genet. 2013;9(2):e1003336.
125.
Luo SY, et al. The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus. Clinical: Epigenetics; 2015. p. 7.
126.
Chafin CB, et al. MicroRNA-let-7a promotes E2F-mediated cell proliferation and NF kappa B activation in vitro. Cell Mol Immunol. 2014;11(1):79–93.PubMedCentralPubMed
127.
Kontaki E, Boumpas DT. Innate immunity in systemic lupus erythematosus: sensing endogenous nucleic acids. J Autoimmun. 2010;35(3):206–11.PubMed
128.
Dai Y, et al. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int. 2009;29(7):749–54.PubMed
129.
Chafin CB, et al. MicroRNA-let-7a expression is increased in the mesangial cells of NZB/W mice and increases IL-6 production in vitro. Autoimmunity. 2013;46(6):351–62.PubMedCentralPubMed
130.
Han L, et al. DNA methylation regulates MicroRNA expression. Cancer Biol Ther. 2007;6(8):1284–8.PubMed
131.
Lujambio A, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci. 2008;105(36):13556–61.PubMedCentralPubMed
132.
Tang JT, et al. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Carcinogenesis. 2011;32(8):1207–15.PubMed
133.
Zhao M, et al. DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype. J Autoimmun. 2014;54:127–36.PubMed
134.
Huttenhofer A, Schattner P, Polacek N. Non-coding RNAs: hope or hype? Trends Genet. 2005;21(5):289–97.PubMed